Literature DB >> 3845793

Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.

G H McCracken, Y Sakata.   

Abstract

The pharmacokinetics and bacteriological efficacies of penicillin G, ceftriaxone, vancomycin, and imipenem were determined in rabbits with experimental meningitis caused by Streptococcus pneumoniae strains with different penicillin susceptibilities. Drug dosages were adjusted to attain peak concentrations in serum that were similar to those observed in infants and children. In animals infected with a penicillin-susceptible (MBC, 0.008 micrograms/ml) pneumococcus, penicillin G and ceftriaxone reduced the number of organisms in cerebrospinal fluid (CSF) by greater than or equal to 4.14 log10 CFU/ml after single doses and after 9-h continuous infusions. A single large dose (50 mg/kg) of penicillin G was comparatively ineffective (-2.15 log10 CFU/ml) against a relatively penicillin-resistant (MBC, 0.5 micrograms/ml) strain, whereas ceftriaxone therapy resulted in a 3.66- and 4.77-log10 CFU/ml reduction after single doses and 9-h continuous infusions, respectively. In animals in which meningitis was caused by a penicillin-resistant (MBC, 8.0 micrograms/ml) pneumococcus, a single dose of penicillin (50 or 150 mg/kg) or of ceftriaxone failed to lower the number of organisms in CSF. Vancomycin and imipenem reduced the counts in CSF by at least 2.19 and 4.10 log10 CFU/ml after single doses and 9-h infusions, respectively. In all experiments, a bactericidal titer of greater than or equal to 1:8 in CSF was necessary to achieve a maximal bacteriological effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3845793      PMCID: PMC176226          DOI: 10.1128/AAC.27.2.141

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Cefamandole in the therapy of experimental pneumococcal meningitis.

Authors:  R J Sheretz; R Dacey; M A Sande
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

2.  Penicillin-resistant pneumococcal meningitis in an immunocompromised infant.

Authors:  J W Mace; D S Janik; R L Sauer; J J Quilligan
Journal:  J Pediatr       Date:  1977-09       Impact factor: 4.406

3.  Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin.

Authors:  A Paredes; L H Taber; M D Yow; D Clark; W Nathan
Journal:  Pediatrics       Date:  1976-09       Impact factor: 7.124

4.  Serial dilution antibiotic sensitivity testing with the microtitrator system.

Authors:  J H Marymont; R M Wentz
Journal:  Am J Clin Pathol       Date:  1966-05       Impact factor: 2.493

5.  Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G.

Authors:  S Naraqi; G P Kirkpatrick; S Kabins
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

6.  Vancomycin therapy of experimental pneumococcal meningitis caused by penicillin-sensitive and resistant strains.

Authors:  T R Beam
Journal:  J Antimicrob Chemother       Date:  1981-01       Impact factor: 5.790

7.  Pneumococci relatively resistant to penicillin: a prevalence survey in children.

Authors:  K C Anderson; M J Maurer; A S Dajani
Journal:  J Pediatr       Date:  1980-12       Impact factor: 4.406

8.  Penicillin-insensitive pneumococci. Case report and review.

Authors:  G A Ahronheim; B Reich; M I Marks
Journal:  Am J Dis Child       Date:  1979-02

9.  Human infection caused by penicillin-insensitive pneumococci.

Authors:  L Devitt; I Riley; D Hansman
Journal:  Med J Aust       Date:  1977-04-16       Impact factor: 7.738

10.  Streptococcus pneumoniae resistant to penicillin and chloramphenicol.

Authors:  P C Appelbaum; A Bhamjee; J N Scragg; A F Hallett; A J Bowen; R C Cooper
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

View more
  18 in total

1.  Streptococcus pneumoniae: Activity of Newer Agents Against Penicillin-Resistant Strains.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

2.  Persistent bacteremia in rabbit fetuses despite maternal antibiotic therapy in a novel intrauterine-infection model.

Authors:  C Gras-Le Guen; T Debillon; C Toquet; A Jarry; N Winer; C Jacqueline; M F Kergueris; E Bingen; J C Roze; G Potel; D Bugnon
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

3.  Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

Authors:  K Tateda; K Takashima; H Miyazaki; T Matsumoto; T Hatori; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

Authors:  M E Falagas; L McDermott; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.

Authors:  C Doit; J Barre; R Cohen; S Bonacorsi; A Bourrillon; E H Bingen
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 6.  Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid.

Authors:  I Lutsar; I R Friedland
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

7.  In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; N Peyrard; A Pechinot; M Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 8.  World-wide development of antibiotic resistance in pneumococci.

Authors:  P C Appelbaum
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

9.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  I R Friedland; M Paris; S Ehrett; S Hickey; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  M M París; S M Hickey; M I Uscher; S Shelton; K D Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.